{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:04:47Z","timestamp":1793531087919,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.biopsych.2017.09.028","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T02:45:21Z","timestamp":1507862721000},"page":"475-483","source":"Crossref","is-referenced-by-count":75,"title":["Prefrontal and Striatal Gamma-Aminobutyric Acid\u00a0Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0773-1642","authenticated-orcid":false,"given":"Camilo","family":"de la Fuente-Sandoval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Reyes-Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangling","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Le\u00f3n-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Rodr\u00edguez-Mayoral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi","family":"Jung-Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Sol\u00eds-Vivanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dikoma C.","family":"Shungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2017.09.028_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamapsychiatry.2015.0533","article-title":"Altered markers of cortical gamma-aminobutyric acid neuronal activity in schizophrenia: Role of the NARP gene","volume":"72","author":"Kimoto","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archpsyc.1995.03950160008002","article-title":"Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics","volume":"52","author":"Akbarian","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(01)00225-1","article-title":"GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder","volume":"25","author":"Benes","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2017.09.028_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.biopsych.2015.03.010","article-title":"Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia","volume":"77","author":"Gonzalez-Burgos","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.biopsych.2014.09.007","article-title":"Prefrontal cortical gamma-aminobutyric acid transmission and cognitive function: Drawing links\u00a0to schizophrenia from preclinical research","volume":"77","author":"Tse","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.schres.2009.11.011","article-title":"GABA concentration in schizophrenia patients and the effects of antipsychotic medication: A proton magnetic resonance spectroscopy study","volume":"117","author":"Tayoshi","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2017.09.028_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.schres.2009.04.026","article-title":"Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study","volume":"112","author":"Goto","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2017.09.028_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archgenpsychiatry.2011.1519","article-title":"Elevated prefrontal cortex gamma-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in\u00a0vivo with proton magnetic resonance spectroscopy","volume":"69","author":"Kegeles","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib9","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/schbul\/sbs092","article-title":"In\u00a0vivo measurements of glutamate, GABA, and NAAG in schizophrenia","volume":"39","author":"Rowland","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2017.09.028_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/mp.2015.34","article-title":"Medial frontal GABA is lower in older schizophrenia: A MEGA-PRESS with macromolecule suppression study","volume":"21","author":"Rowland","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.nicl.2014.10.005","article-title":"GABA and glutamate in schizophrenia: A 7 T (1)H-MRS study","volume":"6","author":"Marsman","year":"2014","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.biopsych.2017.09.028_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1176\/appi.ajp.2015.15020190","article-title":"Prefrontal GABA levels measured with magnetic resonance spectroscopy in patients with psychosis and unaffected siblings","volume":"173","author":"Marenco","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib13","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1523\/JNEUROSCI.6158-09.2010","article-title":"GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression","volume":"30","author":"Yoon","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.09.028_bib14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.biopsych.2016.04.007","article-title":"7T Proton magnetic resonance spectroscopy of gamma-aminobutyric acid, glutamate, and glutamine reveals altered concentrations in patients with schizophrenia and healthy siblings","volume":"81","author":"Thakkar","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pnpbp.2013.07.024","article-title":"Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex","volume":"47","author":"Kelemen","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib16","first-page":"341","article-title":"Comparison of the density of gamma-aminobutyric acid in the ventromedial prefrontal cortex of patients with first-episode psychosis and healthy controls","volume":"27","author":"Yang","year":"2015","journal-title":"Shanghai Arch Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib17","doi-asserted-by":"crossref","first-page":"pyv105","DOI":"10.1093\/ijnp\/pyv105","article-title":"Cortico-striatal GABAergic and glutamatergic dysregulations in subjects at ultra-high risk for psychosis investigated with proton magnetic resonance spectroscopy","volume":"19","author":"de la Fuente-Sandoval","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2017.09.028_bib18","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.npp.1301147","article-title":"Linking the PANSS, BPRS, and CGI: Clinical implications","volume":"31","author":"Leucht","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2017.09.028_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib20","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1073\/pnas.90.12.5662","article-title":"Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in\u00a0vivo","volume":"90","author":"Rothman","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.09.028_bib21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/nbm.3539","article-title":"Brain gamma-aminobutyric acid (GABA) detection in\u00a0vivo\u00a0with the J-editing (1) H MRS technique: A comprehensive methodological evaluation of sensitivity enhancement, macromolecule contamination and test-retest reliability","volume":"29","author":"Shungu","year":"2016","journal-title":"NMR Biomed"},{"key":"10.1016\/j.biopsych.2017.09.028_bib22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.biopsych.2010.05.016","article-title":"Elevated gamma-aminobutyric acid levels in chronic schizophrenia","volume":"68","author":"\u00d6ng\u00fcr","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamapsychiatry.2015.2680","article-title":"Frontal glutamate and gamma-aminobutyric acid levels and their associations with mismatch negativity and digit sequencing task performance in schizophrenia","volume":"73","author":"Rowland","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2017.09.028_bib25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.biopsych.2015.07.022","article-title":"Markedly lower glutamic acid decarboxylase 67 protein levels in a subset of boutons in schizophrenia","volume":"79","author":"Rocco","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature11466","article-title":"Dopaminergic neurons inhibit striatal output through non-canonical release of GABA","volume":"490","author":"Tritsch","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2017.09.028_bib27","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jamapsychiatry.2013.2437","article-title":"Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia","volume":"70","author":"Kraguljac","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/mp.2009.121","article-title":"1H-MRS at 4 tesla in minimally treated early schizophrenia","volume":"15","author":"Bustillo","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/S1461145712000314","article-title":"Striatal glutamate and the conversion to psychosis: A prospective 1H-MRS imaging study","volume":"16","author":"de la Fuente-Sandoval","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2017.09.028_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamapsychiatry.2016.0442","article-title":"Nature of glutamate alterations in schizophrenia: A meta-analysis of proton magnetic resonance spectroscopy studies","volume":"73","author":"Merritt","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib31","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/npp.2011.65","article-title":"Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis","volume":"36","author":"de la Fuente-Sandoval","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2017.09.028_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/schbul\/sbv118","article-title":"Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: A proton magnetic resonance spectroscopy study with implications for glial dysfunction","volume":"42","author":"Plitman","year":"2016","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2017.09.028_bib33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/archpsyc.1997.01830220085012","article-title":"Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy","volume":"54","author":"Bartha","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib34","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","article-title":"Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers","volume":"159","author":"Theberge","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1192\/bjp.bp.106.033670","article-title":"Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia","volume":"191","author":"Theberge","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib36","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamapsychiatry.2013.289","article-title":"Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study","volume":"70","author":"de la Fuente-Sandoval","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1176\/appi.ajp.159.1.130","article-title":"High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia","volume":"159","author":"Bustillo","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.09.028_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/oxfordjournals.schbul.a007049","article-title":"Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals","volume":"29","author":"Wood","year":"2003","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2017.09.028_bib39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/mrm.24291","article-title":"3-T proton magnetic spectroscopy in unmedicated first episode psychosis: A focus on creatine","volume":"69","author":"Tibbo","year":"2013","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.biopsych.2017.09.028_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pscychresns.2008.06.002","article-title":"Creatine abnormalities in schizophrenia and bipolar disorder","volume":"172","author":"Ong\u00fcr","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2017.09.028_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2014.04.020","article-title":"Motor cortex glutathione deficit in ALS measured in\u00a0vivo with the J-editing technique","volume":"570","author":"Weiduschat","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2017.09.028_bib42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mrm.1910320304","article-title":"Analysis of macromolecule resonances in 1H NMR spectra of human brain","volume":"32","author":"Behar","year":"1994","journal-title":"Magn Reson Med"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322317320504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322317320504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T12:30:48Z","timestamp":1570192248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322317320504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0006322317320504"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2017.09.028","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}